Management of nonulcer dyspepsia

New England Journal of Medicine

Volumn 339, Issue 19, 1998, Pages 1376-1381

  Fisher, Robert S ^a   Parkman, Henry P ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; CISAPRIDE; DOMPERIDONE; FEDOTOZINE; GRANISETRON; HISTAMINE H2 RECEPTOR ANTAGONIST; METOCLOPRAMIDE; OCTREOTIDE; OMEPRAZOLE; ONDANSETRON; PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

BILE REFLUX; DIFFERENTIAL DIAGNOSIS; DYSPEPSIA; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE MOTILITY; PARASITISM; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; STOMACH ACID SECRETION; ULCER;

DIAGNOSIS, DIFFERENTIAL; DYSPEPSIA; ENDOSCOPY, DIGESTIVE SYSTEM; GASTROINTESTINAL AGENTS; HUMANS;

EID: 0032487919     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199811053391907     Document Type: Review

References (59)

1. Talley NJ, Phillips SF. Non-ulcer dyspepsia: potential causes and pathophysiology. Ann Intern Med 1988;108:865-79.
2. Camilleri M. Nonulcer dyspepsia: a look into the future. Mayo Clin Proc 1996;71:614-22.
3. Barbara L, Camilleri M, Corinaldesi R, et al. Definition and investigation of dyspepsia - consensus of an international ad hoc working party. Dig Dis Sci 1989;34:1272-6.
4. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ III. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992; 102:1259-68.
5. Jones R, Lydeard S. Prevalence of symptoms of dyspepsia in the community. BMJ 1989;298:30-2.
6. Brown C, Rees WDW. Dyspepsia in general practice. BMJ 1990;300: 829-30.
7. Nyren O, Adami HO, Gustavsson S, Loof L. Excess sick-listing in non-ulcer dyspepsia. J Clin Gastroenterol 1986;8:339-45.
8. Richter JE. Dyspepsia: organic causes and differential characteristics from functional dyspepsia. Scand J Gastroenterol Suppl 1991;182:11-6.
9. Talley NJ, Silverstein MD, Agreus L, Nyren O, Sonnenberg A, Holtmann G. Evaluation of dyspepsia. Gastroenterology 1998;114:582-95.
10. Johannessen T, Petersen H, Klevell PM, et al. The predictive value of history in dyspepsia. Scand J Gastroenterol 1990;25:689-97.
11. Talley NJ, Colin-Jones D, Koch KL, Koch M, Nyren O, Stanghellini V. Functional dyspepsia: a classification with guidelines of diagnosis and management. Gastroenterol Int 1991;4:145-60.
12. Malagelada J-R. Functional dyspepsia - insights on mechanisms and management strategies. Gastroenterol Clin North Am 1996;25:103-12.
13. Spiro HM. Moynihan's disease? The diagnosis of duodenal ulcer. N Engl J Med 1974;291:567-9.
14. Sircus W. Duodenitis: a clinical, endoscopic and histopathologic study. QJM 1985;56:593-600.
15. Tytgat GN, Noach LA, Rauws EAJ. Is gastroduodenitis a cause of chronic dyspepsia? Scand J Gastroenterol Suppl 1991;182:33-9.
16. Johnsen R, Bernersen B, Straume B, Forde OH, Bostad L, Burhol PG. Prevalences of endoscopic and histological findings in subjects with and without dyspepsia. BMJ 1991;302:749-52.
17. Tytgat GNJ. Current indications for Helicobacter pylori eradication therapy. Scand J Gastroenterol Suppl 1996;215:70-3.
18. Armstrong D. Helicobacter pylori infection and dyspepsia. Scand J Gastroenterol Suppl 1996;215:38-47.
19. Veldhuyzen van Zanten SJ, Sherman PM. Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview. Can Med Assoc J 1994;150:177-85.
20. Marshall BJ, Armstrong JA, McGechie DB, Glancy RJ. Attempt to fulfill Koch's postulates for pyloric Campylobacter. Med J Aust 1985;142:436-9.
21. O'Morain C, Buckley M. Helicobacter pylori and dyspepsia. Scand J Gastroenterol Suppl 1996;214:28-30.
22. Talley NJ. A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology 1994;106:1174-83.
23. Bost R, Hostein J, Valenti M, et al. Is there an abnormal fasting duodenogastric reflux in nonulcer dyspepsia? Dig Dis Sci 1990;35:193-9.
24. Oh JJ, Kim CH. Gastroparesis after a presumed viral illness: clinical and laboratory features and natural history. Mayo Clin Proc 1990;65:636-42.
25. Toskes PP. Medical therapy of chronic pancreatitis. Semin Gastrointest Dis 1991;2:188-93.
26. Richter JE. Stress and psychologic and environmental factors in functional dyspepsia. Scand J Gastroenterol Suppl 1991;182:40-6.
27. Mayer EA, Raybould HE. Role of visceral afferent mechanisms in functional bowel disorders. Gastroenterology 1990;99:1688-704.
28. Mearin F, Cucala M, Azpiroz F, Malagelada JR. The origin of symptoms on the brain-gut axis in functional dyspepsia. Gastroenterology 1991; 101:999-1006.
29. Small PK, Loudon MA, Waldron B, Smith D, Campbell FC. Importance of reflux symptoms in functional dyspepsia. Gut 1995;36:189-92.
30. Malagelada J-R, Stanghellini V. Manometric evaluation of functional upper gut symptoms. Gastroenterology 1985;88:1223-31.
31. Stanghellini V, Tosetti C, Paternico A, et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996;110:1036-42.
32. Koch KL, Stern RM, Stewart WR, Vasey MW. Gastric emptying and gastric myoelectrical activity in patients with diabetic gastroparesis: effect of long-term domperidone treatment. Am J Gastroenterol 1989;84:1069-75.
33. Scott AM, Kellow JE, Shuter B, et al. Intragastric distribution and gastric emptying of solids and liquids in functional dyspepsia: lack of influence of symptom subgroups and H. pylori-associated gastritis. Dig Dis Sci 1993;38:2247-54.
34. Troncon LEA, Bennett RJM, Ahluwalia NK, Thompson DG. Abnormal intragastric distribution of food during gastric emptying in functional dyspepsia patients. Gut 1994;35:327-32.
35. Hogan WJ, Geenen JE. Biliary dyskinesia. Endoscopy 1988;20:Suppl 1:1179-83.
36. Dobrilla G, Comberlato M, Steele A, Vallaperta P. Drug treatment of functional dyspepsia - a meta-analysis of randomized controlled clinical trials. J Clin Gastroenterol 1989;11:169-77.
37. Veldhuyzen van Zanten SJO, Cleary C, Talley NJ, et al. Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol 1996;91:660-73.
38. Nyrén O, Adami H-O, Bates S, et al. Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med 1986; 314:339-43.
39. Carlsson R, Bolling E, Jerndal P, Junghard O, Lauritsen K, Glise H. Factors predicting response to omeprazole treatment in patients with functional dyspepsia. Gastroenterology 1996;110:Suppl:A76. abstract.
40. Meineche-Schmidt V, Krag E, Christensen E. Identification of omeprazole response in dyspepsia: data analysis of a Danish multicenter trial in general practice. Gastroenterology 1995;108:Suppl:A165. abstract.
41. Halter F, Miazza B, Brignoli R. Cisapride or cimetidine in the treatment of functional dyspepsia: results of a double-blind, randomized, Swiss multicentre study. Scand J Gastroenterol 1994;29:618-23.
42. McQuaid K. Dyspepsia. In: Feldman M, Scharschmidt BF, Sleisenger MH, eds. Sleisenger and Fordtran's gastrointestinal and liver disease: pathophysiology/diagnosis/management. 6th ed. Vol. 1. Philadelphia: W.B. Saunders, 1998:105-17.
43. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. Helicobacter pylori in peptic ulcer disease. JAMA 1994;272: 65-9.
44. McColl KEL, el-Nujumi A, Murray L, et al. The Helicobacter pylori breath test: a surrogate marker for peptic ulcer disease in dyspeptic patients. Gut 1997;40:302-6.
45. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-31.
46. Milne R, Logan RPH, Harwood D, Misiewicz JJ, Forman D. Helicobacter pylori and upper gastrointestinal disease: a survey of gastroenterologists in the United Kingdom. Gut 1995;37:314-8.
47. Clouse RE. Antidepressants for functional gastrointestinal syndromes. Dig Dis Sci 1994;39:2352-63.
48. Fraitag B, Homerin M, Hecketsweiler P. Double-blind dose-response multicenter comparison of fedotozine and placebo in treatment of nonulcer dyspepsia. Dig Dis Sci 1994;39:1072-7
49. Bytzer P, Hansen JM, Schaffalitzky de Muckadell OB. Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet 1994;343:811-6.
50. Health and Public Policy Committee, American College of Physicians. Endoscopy in the evaluation of dyspepsia. Ann Intern Med 1985;102:266-9.
51. Williams B, Luckas M, Ellingham JHM, Dain A, Wicks ACB. Do young patients with dyspepsia need investigation? Lancet 1988;2:1349-51.
52. Christie J, Shepherd NA, Codling BW, Valori RM. Gastric cancer below the age of 55: implications for screening patients with uncomplicated dyspepsia. Gut 1997;41:513-7.
53. Jones R. What happens to patients with non-ulcer dyspepsia after endoscopy? Practitioner 1988;232:75-6.
54. Axon ATR. Chronic dyspepsia: who needs endoscopy? Gastroenterology 1997;112:1376-80.
55. Fendrick AM, Chernew ME, Hirth RA, Bloom BS. Alternative management strategies for patients with suspected peptic ulcer disease. Ann Intern Med 1995;123:260-8.
56. Silverstein MD, Petterson T, Talley NJ. Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology 1996;110:72-83.
57. Walsh JH, Peterson WL. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N Engl J Med 1995;333:984-91.
58. Ofman JJ, Etchason J, Fullerton S, Kahn KL, Soll AH. Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: clinical and economic consequences. Ann Intern Med 1997;126:280-91.
59. Talley NJ. Functional dyspepsia - should treatment be targeted on disturbed physiology? Aliment Pharmacol Ther 1995;9:107-15.